Werewolf Therapeutics, Inc.

HOWL · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 39 employees
78
SEC Filings
$0.466
Close 2026-06-01
39
Employees

Business Summary

PART I Company Overview We are an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the bodys immune system for the treatment of cancer and other immune-mediated conditions. We are leveraging our proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Our molecules, which we refer to ...

Latest Stock Quote

HOWL 2026-06-01 $0.466 O:$0.457 H:$0.495299 L:$0.45 Vol:0.4M VWAP:$0.4745
origin leaf: ab43b5fe157c9a0b1c669334189fd190c713fa2cede0a5c1818996095a92b0b9

Next Earnings

Q2 FY2026 — expected 2026-08-10

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-272025-12-310001785530-26-000006EDGAR117K words
2025-03-112024-12-310001785530-25-000008EDGAR—
2024-03-072023-12-310001785530-24-000012EDGAR—
2023-03-232022-12-310001785530-23-000009EDGAR—
2022-03-242021-12-310001785530-22-000014EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001785530-25-000031EDGAR71K words
2025-08-142025-06-300001785530-25-000021EDGAR—
2025-05-082025-03-310001785530-25-000014EDGAR—
2024-11-072024-09-300001785530-24-000034EDGAR—
2024-08-082024-06-300001785530-24-000028EDGAR—
2024-05-032024-03-310001785530-24-000020EDGAR—
2023-11-142023-09-300001785530-23-000033EDGAR—
2023-08-102023-06-300001785530-23-000025EDGAR—
2023-05-112023-03-310001785530-23-000017EDGAR—
2022-11-102022-09-300001785530-22-000038EDGAR—
2022-08-112022-06-300001785530-22-000031EDGAR—
2022-05-102022-03-310001785530-22-000021EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001785530-26-000005EDGAR2K words
2026-02-240001193125-26-067569EDGAR—
2026-02-130001193125-26-051455EDGAR—
2026-02-060001193125-26-041305EDGAR—
2025-12-180001193125-25-323787EDGAR—
2025-11-040001785530-25-000030EDGAR—
2025-10-060001193125-25-231953EDGAR—
2025-08-140001785530-25-000020EDGAR—
2025-06-130001193125-25-140727EDGAR—
2025-05-150001193125-25-120910EDGAR—

78 total filings indexed. 51 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001785530
TickerHOWL
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.werewolftx.com
Listed2021-04-30

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: d867d60517997b4f5534f113790357dab6675c1a5863b3a35db5053747014841
parent: ef4dd53643371e877146533130d8d22ae15c1665ab038d25bccdc44720679f2e
content hash: c5e6bcbb5b0d971533c2cd92809349fa96c1a0f598ceb504674b72542de77dec
signed: 2026-06-02T19:01:25.746Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf